Merck KGAA: stock up after Q2 results.
(CercleFinance.com) - Contrary to the trend in Frankfurt, the Merck KGaA stock is up 0.
6% this morning, after the group announced a 35% leap in Q2 earnings to 421 million euros.
However, excluding extraordinary items, EPS remained almost flat at 1.54 euro.
EBITDA, excluding extraordinary items, fell by 5.6% to 1.1 billion euros, meaning a margin that is down 2.3 points at 28.1%, as a result of investments in healthcare and normalisation of the liquid crystal market.
Revenues rose 2.3% to 3.9 billion euros - both as reported and in organic terms, driven by the group's health and life sciences businesses. The group made almost one third of net sales in the Asia-Pacific region.
Copyright (c) 2017 CercleFinance.com. All rights reserved.
6% this morning, after the group announced a 35% leap in Q2 earnings to 421 million euros.
However, excluding extraordinary items, EPS remained almost flat at 1.54 euro.
EBITDA, excluding extraordinary items, fell by 5.6% to 1.1 billion euros, meaning a margin that is down 2.3 points at 28.1%, as a result of investments in healthcare and normalisation of the liquid crystal market.
Revenues rose 2.3% to 3.9 billion euros - both as reported and in organic terms, driven by the group's health and life sciences businesses. The group made almost one third of net sales in the Asia-Pacific region.
Copyright (c) 2017 CercleFinance.com. All rights reserved.